AI-based precision oncology clinical study platform
Total Trials
8
As Lead Sponsor
6
As Collaborator
2
Total Enrollment
16,602
NCT03793088
A Patient-Centric Platform Trial for Precision Oncology
Phase: N/A
Role: Lead Sponsor
Start: Feb 7, 2019
Completion: Jan 31, 2026
NCT04321811
Behavior, Environment And Treatments for Covid-19
Start: Mar 21, 2020
Completion: Mar 20, 2021
NCT05052372
Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib
Start: Nov 21, 2021
Completion: Dec 20, 2022
NCT05461430
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
Role: Collaborator
Start: Jul 15, 2022
Completion: Jul 31, 2028
NCT06140719
xPedite: A Study to Expedite DIPG and DMG Research
Start: Nov 1, 2023
Completion: Jan 31, 2027
NCT06539169
FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
Start: Jun 10, 2024
Completion: Jun 10, 2026
Loading map...